BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 23911181)

  • 1. Noninvasive skin fluorescence spectroscopy is comparable to hemoglobin A1c and fasting plasma glucose for detection of abnormal glucose tolerance.
    Olson BP; Matter NI; Ediger MN; Hull EL; Maynard JD
    J Diabetes Sci Technol; 2013 Jul; 7(4):990-1000. PubMed ID: 23911181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noninvasive skin fluorescence spectroscopy for detection of abnormal glucose tolerance.
    Hull EL; Matter NI; Olson BP; Ediger MN; Magee AJ; Way JF; Vugrin KE; Maynard JD
    J Clin Transl Endocrinol; 2014 Sep; 1(3):92-99. PubMed ID: 29159089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noninvasive type 2 diabetes screening: clinical evaluation of SCOUT DS in an Asian Indian cohort.
    Mohan V; Rani CS; Regin BS; Balasubramanyam M; Anjana RM; Matter NI; Poongothai S; Deepa M; Pradeepa R
    Diabetes Technol Ther; 2013 Jan; 15(1):39-45. PubMed ID: 23150995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined use of fasting plasma glucose and glycated hemoglobin A1c in the screening of diabetes and impaired glucose tolerance.
    Hu Y; Liu W; Chen Y; Zhang M; Wang L; Zhou H; Wu P; Teng X; Dong Y; Zhou Jw; Xu H; Zheng J; Li S; Tao T; Hu Y; Jia Y
    Acta Diabetol; 2010 Sep; 47(3):231-6. PubMed ID: 19760291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noninvasive type 2 diabetes screening: superior sensitivity to fasting plasma glucose and A1C.
    Maynard JD; Rohrscheib M; Way JF; Nguyen CM; Ediger MN
    Diabetes Care; 2007 May; 30(5):1120-4. PubMed ID: 17337498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noninvasive skin fluorescence spectroscopy for diabetes screening.
    Stirban A
    J Diabetes Sci Technol; 2013 Jul; 7(4):1001-4. PubMed ID: 23911182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of abnormal glucose tolerance in Africans is improved by combining A1C with fasting glucose: the Africans in America Study.
    Sumner AE; Thoreson CK; O'Connor MY; Ricks M; Chung ST; Tulloch-Reid MK; Lozier JN; Sacks DB
    Diabetes Care; 2015 Feb; 38(2):213-9. PubMed ID: 25338926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of high-normal levels of haemoglobin A(1C) and fasting plasma glucose for diabetes screening and for prediction: a meta-analysis.
    Kodama S; Horikawa C; Fujihara K; Hirasawa R; Yachi Y; Yoshizawa S; Tanaka S; Sone Y; Shimano H; Iida KT; Saito K; Sone H
    Diabetes Metab Res Rev; 2013 Nov; 29(8):680-92. PubMed ID: 23963843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of performance of A1c and FPG tests for screening newly diagnosed diabetes defined by an OGTT among tuberculosis patients-a study from India.
    Kumpatla S; Aravindalochanan V; Rajan R; Viswanathan V; Kapur A
    Diabetes Res Clin Pract; 2013 Oct; 102(1):60-4. PubMed ID: 24035281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for HbA1c-defined prediabetes and diabetes in an at-risk greek population: performance comparison of random capillary glucose, the ADA diabetes risk test and skin fluorescence spectroscopy.
    Tentolouris N; Lathouris P; Lontou S; Tzemos K; Maynard J
    Diabetes Res Clin Pract; 2013 Apr; 100(1):39-45. PubMed ID: 23369230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycated Hemoglobin Is Suboptimal for the Screening of Prediabetes and Type 2 Diabetes in Adults With Nonalcoholic Fatty Liver Disease.
    Gignac T; Trépanier G; Paquet V; Ferland S; Carreau AM
    Can J Diabetes; 2023 Oct; 47(7):603-610. PubMed ID: 37352972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of an A1C and fasting capillary blood glucose test for screening newly diagnosed diabetes and pre-diabetes defined by an oral glucose tolerance test in Qingdao, China.
    Zhou X; Pang Z; Gao W; Wang S; Zhang L; Ning F; Qiao Q
    Diabetes Care; 2010 Mar; 33(3):545-50. PubMed ID: 20007941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 1h post glucose value best predicts future dysglycemia among normal glucose tolerance subjects.
    Sai Prasanna N; Amutha A; Pramodkumar TA; Anjana RM; Venkatesan U; Priya M; Pradeepa R; Mohan V
    J Diabetes Complications; 2017 Nov; 31(11):1592-1596. PubMed ID: 28916170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of haemoglobin A1c and fasting plasma glucose for incident diabetes and implications for screening.
    Schöttker B; Raum E; Rothenbacher D; Müller H; Brenner H
    Eur J Epidemiol; 2011 Oct; 26(10):779-87. PubMed ID: 21947790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of diagnostic utility of fasting plasma glucose and HbA1c in stable renal transplant recipients one year after transplantation.
    Ussif AM; Åsberg A; Halden TAS; Nordheim E; Hartmann A; Jenssen T
    BMC Nephrol; 2019 Jan; 20(1):12. PubMed ID: 30630438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose challenge test screening for prediabetes and undiagnosed diabetes.
    Phillips LS; Ziemer DC; Kolm P; Weintraub WS; Vaccarino V; Rhee MK; Chatterjee R; Narayan KM; Koch DD
    Diabetologia; 2009 Sep; 52(9):1798-807. PubMed ID: 19557386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of A1C, fasting and 2-h post-load plasma glucose criteria to diagnose diabetes in Italian Caucasians.
    Marini MA; Succurro E; Arturi F; Ruffo MF; Andreozzi F; Sciacqua A; Lauro R; Hribal ML; Perticone F; Sesti G
    Nutr Metab Cardiovasc Dis; 2012 Jul; 22(7):561-6. PubMed ID: 21944738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fasting plasma glucose and glycated haemoglobin in the screening of diabetes and impaired glucose tolerance.
    Mannucci E; Ognibene A; Sposato I; Brogi M; Gallori G; Bardini G; Cremasco F; Messeri G; Rotella CM
    Acta Diabetol; 2003 Dec; 40(4):181-6. PubMed ID: 14740278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternative indices of glucose homeostasis as biochemical diagnostic tests for abnormal glucose tolerance in an African setting.
    Kengne AP; Erasmus RT; Levitt NS; Matsha TE
    Prim Care Diabetes; 2017 Apr; 11(2):119-131. PubMed ID: 28132763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing HbA1c, fasting and 2-h plasma glucose for screening for abnormal glucose regulation in patients undergoing coronary angiography.
    Wang JS; Lee IT; Lee WJ; Lin SY; Fu CP; Lee WL; Liang KW; Sheu WH
    Clin Chem Lab Med; 2015 Aug; 53(9):1441-9. PubMed ID: 25405720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.